Your shopping cart is currently empty

KT-333 ammonium (Compound A) acts as a molecular glue that targets and promotes the degradation of the STAT3 protein through the ubiquitin-proteasome system. This compound achieves selective degradation by binding simultaneously to the STAT3 protein and the E3 ubiquitin ligase von Hippel-Lindau protein (VHL). It exhibits strong selectivity and efficacy in degrading STAT3, possessing notable antitumor properties. KT-333 ammonium is particularly useful for research on hematologic malignancies, including large granular lymphocytic leukemia (LGL-L), peripheral T-cell lymphoma (PTCL), and cutaneous T-cell lymphoma (CTCL) [1].

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | KT-333 ammonium (Compound A) acts as a molecular glue that targets and promotes the degradation of the STAT3 protein through the ubiquitin-proteasome system. This compound achieves selective degradation by binding simultaneously to the STAT3 protein and the E3 ubiquitin ligase von Hippel-Lindau protein (VHL). It exhibits strong selectivity and efficacy in degrading STAT3, possessing notable antitumor properties. KT-333 ammonium is particularly useful for research on hematologic malignancies, including large granular lymphocytic leukemia (LGL-L), peripheral T-cell lymphoma (PTCL), and cutaneous T-cell lymphoma (CTCL) [1]. |
| In vitro | KT-333 ammonium, at a concentration of (11.8±2.3 nM over 48 hours), causes irreversible growth inhibition and induces the activity of caspase 3/7, a marker of apoptosis, in the SU-DHL-1 cell line following STAT3 degradation [1]. Additionally, KT-333 ammonium demonstrates STAT3 protein degradation with GI50 values ranging from 8.1 to 57.4 nM across various ALCL cell lines in cell phenotype analysis [1]. |
| In vivo | KT-333 ammonium exhibited dose-dependent antitumor activity when administered intravenously at doses of 5, 10, 15, and 45 mg/kg once weekly for two weeks. Mice receiving 5 mg/kg showed 79.9% tumor growth inhibition (TGI), while doses of 10, 15, or 45 mg/kg led to complete tumor regression, sustained until the study's conclusion [1]. Similarly, doses of 10, 20, and 30 mg/kg resulted in dose-dependent antitumor effects, with mice given 10 mg/kg achieving 83.8% TGI, and those receiving 20 or 30 mg/kg experiencing complete tumor regression, also persisting through to the end of the study [1]. |
| Molecular Weight | 1274.81 |
| Formula | C60H77ClN11O14PS |
| Cas No. | 2839758-34-6 |
| Smiles | ClC(C(CCCC(N[C@@H](C(C)(C)C)C(N1[C@@H](C[C@H](C1)O)C(N[C@H](C2=CC=C(C3=C(N=CS3)C)C=C2)C)=O)=O)=O)=CC=C4)=C4OC[C@H](CCC(N)=O)NC([C@H]5N6[C@](CCN(C[C@@H](C6=O)NC(C7=CC8=CC(C(P(O)([O-])=O)=O)=CC=C8N7)=O)C(C)=O)([H])CC5)=O.[NH4+] |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.